Aladdin Healthcare Technologies SE:Aladdin Healthcare Technologies SE ernennt David C. Rubinsztein zum neuen Chief Scientific Advisor | Press Release - EQS News
![Aladdin Healthcare Technologies SE : Shareholders Board Members Managers and Company Profile | DE000A12ULL2 | MarketScreener Aladdin Healthcare Technologies SE : Shareholders Board Members Managers and Company Profile | DE000A12ULL2 | MarketScreener](https://www.marketscreener.com/static/address/120973069.png)
Aladdin Healthcare Technologies SE : Shareholders Board Members Managers and Company Profile | DE000A12ULL2 | MarketScreener
![Aladdin Healthcare Technologies erwirbt Beteiligung am Spin-off No-Age Biotech Inc. an der TSX: E-HEALTH-COM Aladdin Healthcare Technologies erwirbt Beteiligung am Spin-off No-Age Biotech Inc. an der TSX: E-HEALTH-COM](https://e-health-com.de/fileadmin/_processed_/b/4/csm_Alladin_Logo_a80ce5807c.png)